Should You Stop SIPs in a Market Crash?
Over the last month, our inbox and phone have been full of the same two questions from investors: “Should I stop my SIPs?” and “Should I sell now and buy back when markets bottom out?” Both questions come from the same place – fear. And both lead to the same destination — permanent loss of […]
Gala Precision Engineering: Stock Analysis
Investment Thesis Gala is a business construct we’ve seen converge across geographies: small-value, high-criticality components; long approval cycles; customers structurally unable to be price-sensitive; revenue that behaves like an annuity once designed in. Gala runs a milder, more contested version of that template than the aerospace-grade purists – but it pairs it with a visible capacity […]
How Freshara Is Moving Up the Global Food Value Chain
Incorporated in 2015, Freshara Agro Exports Ltd is a producer and exporter of preserved gherkins and related products, Freshara specializes in procurement, processing, and exporting preserved gherkins and pickled vegetables. Its products are certified by FSSAI, FDA, Star-K Kosher, APEDA, IFS, and BRCGS, meeting international quality standards The “local” Arbitrage Industry Analysis: The Global Pickle […]
KMC Speciality Hospitals- Stock Analysis
Most investors looking at Indian hospital stocks instinctively reach for Apollo, Max, Fortis, or Narayana. KMC Speciality Hospitals doesn’t make that list. It’s a sub-₹1,500 Cr market-cap small-cap that operates exactly one hospital – a 450-bed multi-specialty facility in Tiruchirapalli (Trichy), Tamil Nadu – and yet has compounded into one of the more interesting under-the-radar […]
Ceinsys Tech: Picks and Shovels for Digital India
Some businesses look boring on the surface and stay boring. Others look boring and quietly turn into compounding machines because they sit at the intersection of multiple structural tailwinds. Ceinsys Tech — now rebranded CS Tech AI — belongs in the second bucket, but the price action over the past year tells you the market […]
Windlas Biotech: CDMO Compounder Hiding in Plain Sight
Everyone wants to own the next Cipla or Sun Pharma. Nobody wants to own the company that actually makes the pills those brands sell. That’s exactly why Windlas Biotech is interesting. At ₹867 (April 17, 2026), the stock sits ~24% below its 52-week high of ₹1,140, trading at ~27x trailing earnings, a ~3.4x price-to-book, and […]
Tips Music- Catalog is the new Oil
For decades, India’s music catalogues were like untapped oil fields. Labels like Tips spent years acquiring rights — painstakingly, track by track — only to watch their potential choked by piracy, weak copyright enforcement, and telecom bundling that crushed pricing power. Owning a catalogue often meant sitting on an asset earning a trickle of royalties, […]
What should you do with your portfolio right now?
If you have been waiting to invest when the market has bottomed out, let me assure you – you won’t be able to invest anywhere below the price at which you decided to start waiting in the first place. It’s been some time since I last put pen to paper—or, more accurately, fingers to keyboard. […]
China Market Rebound: Opportunity or Risk for Investors?
Over the past week, the Hang Seng Index and the CSI 300 Index of china have experienced a dramatic reversal, transforming significant one-year declines into robust gains within days. Market sentiment has shifted decisively from a stance of “Anything But China” to “All In, Buy China.” Hang Seng Index Overview As of October 7, 2024, […]
Credit Rating Industry in India A Sunset Sector?
Credit rating business has fantastic economics. They enjoy superior operating margins in ~30% consistent, solid return ratios i.e Return on equity of about 30%. The business requires no debt. The only expense on their books is qualified personnel. FINANCIAL STATEMENT ANALYSIS (Rs in Cr) CRISIL Dec-19 Dec-20 Dec-21 Dec-22 Dec-23 TTM Sales 1,732 1,982 2,301 […]